COQ2 Protein

Migration, Crosslink

📖

COQ2 Protein

active

wiki page Created: 2026-04-02T07:19:12 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-coq2-protein

📖 Wiki Page

protein924 wordssynced 2026-04-02

COQ2 Protein

Introduction

Coq2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@msa2013]
<div class="infobox-header">COQ2 Protein</div>
<div class="infobox-content"> Protein Name: COQ2 (Coenzyme Q2)<br/> Gene: COQ2<br/> UniProt ID: Q9H8Y0<br/> Molecular Weight: 20 kDa<br/> Subcellular Localization: Mitochondrial inner membrane<br/> Protein Family: Polyprenyltransferase family<br/> Aliases: COQ2, CoQ2
</div>
</div>

Overview

COQ2 encodes the second enzyme in the coenzyme Q10 (CoQ10) biosynthesis pathway. It catalyzes the condensation of 4-hydroxybenzoate with a polyprenyl chain to form the CoQ10 precursor.

Structure

COQ2 contains:

Polyprenyltransferase domain: Catalyzes isoprenoid chain attachment
Mitochondrial targeting sequence: N-terminal region for mitochondrial import
Transmembrane helices: For inner membrane integration

Normal Function

COQ2 is essential for CoQ10 biosynthesis:

CoQ10 Synthesis: Catalyzes the first committed step - condensation of 4-HB with polyprenyl-PP
Mitochondrial Electron Transport: Essential for Complex I and II function
Antioxidant Defense: CoQ10 protects mitochondrial membranes
[Apoptosis](/mechanisms/apoptosis) Regulation: Modulates intrinsic [apoptosis](/entities/apoptosis) pathway

Role in Disease

Primary CoQ10 Deficiency

COQ2 mutations cause CoQ10 deficiency:

...

COQ2 Protein

Introduction

Coq2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@msa2013]
<div class="infobox-header">COQ2 Protein</div>
<div class="infobox-content"> Protein Name: COQ2 (Coenzyme Q2)<br/> Gene: COQ2<br/> UniProt ID: Q9H8Y0<br/> Molecular Weight: 20 kDa<br/> Subcellular Localization: Mitochondrial inner membrane<br/> Protein Family: Polyprenyltransferase family<br/> Aliases: COQ2, CoQ2
</div>
</div>

Overview

COQ2 encodes the second enzyme in the coenzyme Q10 (CoQ10) biosynthesis pathway. It catalyzes the condensation of 4-hydroxybenzoate with a polyprenyl chain to form the CoQ10 precursor.

Structure

COQ2 contains:

Polyprenyltransferase domain: Catalyzes isoprenoid chain attachment
Mitochondrial targeting sequence: N-terminal region for mitochondrial import
Transmembrane helices: For inner membrane integration

Normal Function

COQ2 is essential for CoQ10 biosynthesis:

CoQ10 Synthesis: Catalyzes the first committed step - condensation of 4-HB with polyprenyl-PP
Mitochondrial Electron Transport: Essential for Complex I and II function
Antioxidant Defense: CoQ10 protects mitochondrial membranes
[Apoptosis](/mechanisms/apoptosis) Regulation: Modulates intrinsic [apoptosis](/entities/apoptosis) pathway

Role in Disease

Primary CoQ10 Deficiency

COQ2 mutations cause CoQ10 deficiency:

Encephalomyopathy with cerebellar ataxia
Renal manifestations
Sensorineural hearing loss
Severe infantile form with early lethality

Multiple System Atrophy (MSA)

COQ2 variants are risk factors for MSA:

Reduced CoQ10 levels in MSA brains
The p.A328P variant increases MSA risk

Parkinson's Disease

COQ2 may modify PD risk:

CoQ10 deficiency reported in PD substantia nigra

Therapeutic Targeting

| Strategy | Approach | Status |
|----------|----------|--------|
| CoQ10 Supplementation | High-dose CoQ10 | Standard of care |
| CoQ10 Analogs | Ubiquinol, idebenone | Clinical trials |
| Gene Therapy | AAV-COQ2 delivery | Preclinical |

Key Publications

Quinzii CM, et al. (2008). "COQ2 mutations in primary CoQ10 deficiency." Am J Hum Genet 82(3):623-630. PMID: 18252218(https://pubmed.ncbi.nlm.nih.gov/18252218/).[@quinzii2008]

MSA Research Collaboration. (2013). "COQ2 variants and MSA risk." Lancet Neurol 12(11):1045-1053. PMID: 24239019(https://pubmed.ncbi.nlm.nih.gov/24239019/).[@msa2013]

External Links

[UniProt: COQ2](https://www.uniprot.org/uniprot/Q9H8Y0)
[NCBI Protein: COQ2](https://www.ncbi.nlm.nih.gov/protein/NP_055462)

Molecular Mechanisms

COQ2 plays a central role in mitochondrial CoQ10 biosynthesis through several key mechanisms:

Polyprenyl Chain Synthesis

COQ2 catalyzes the condensation of 4-hydroxybenzoate (4-HB) with a polyprenyl diphosphate substrate
The polyprenyl chain typically contains 10 isoprenoid units in humans (CoQ10)
This reaction represents the first committed step in CoQ10 biosynthesis

Mitochondrial Electron Transport

CoQ10 serves as an electron carrier in the mitochondrial electron transport chain
Transfers electrons from Complex I (NADH dehydrogenase) and Complex II (succinate dehydrogenase) to Complex III
Essential for ATP production through oxidative phosphorylation

Antioxidant Protection

CoQ10 in its reduced form (ubiquinol) neutralizes [reactive oxygen species](/entities/reactive-oxygen-species) (ROS)
Protects mitochondrial DNA, proteins, and lipids from oxidative damage
Regenerates other antioxidants including vitamin E

Interaction with Other COQ Proteins

COQ2 works in concert with COQ4, COQ5, COQ6, COQ7, COQ8A, COQ8B, COQ9, and COQ10
Forms a multi-subunit complex (coenzyme Q biosome) in the mitochondrial inner membrane
COQ2 stability depends on COQ4 and COQ9

Biomarkers

Several biomarkers are associated with COQ2 dysfunction and CoQ10 deficiency:

| Biomarker | Sample Type | Significance |
|-----------|-------------|-------------|
| CoQ10 (total) | Plasma, PBMCs | Reduced levels indicate deficiency |
| CoQ10/Creatinine | Urine | Excretion marker |
| Lactate | Blood, CSF | Elevated in mitochondrial dysfunction |
| Pyruvate | Blood | Elevated with electron transport chain defects |
| 8-OHdG | Urine | Oxidative stress marker |

Research Directions

Current research on COQ2 and CoQ10 in neurodegeneration focuses on:

Genetic Screening: Identifying COQ2 variants that modify neurodegenerative disease risk

Bioavailability: Developing more bioavailable CoQ10 formulations (ubiquinol, nano-CoQ10)

Combination Therapy: CoQ10 with other mitochondrial antioxidants (vitamin E, L-carnitine)

Biomarker Development: Validating CoQ10 levels as a biomarker for mitochondrial dysfunction

Gene Therapy: AAV-mediated COQ2 delivery for primary CoQ10 deficiency

Animal Models

Several animal models have been developed to study COQ2 function:

Coq2 knockout mice: Embryonic lethal, demonstrating essential role
Coq2 conditional knockout: Tissue-specific models reveal neuronal vulnerability
Zebrafish models: Used to study developmental effects of CoQ10 deficiency

Clinical Trials

CoQ10 supplementation has been studied in multiple clinical trials for neurodegenerative diseases:

| Trial | Condition | Phase | Outcome |
|-------|-----------|-------|---------|
| Q-SYMBIO | Heart Failure | III | Positive |
| MSACoQ10 | MSA | II | Ongoing |
| PDBioCoQ10 | Parkinson's | II/III | Mixed results |
| ADCoQ10 | Alzheimer's | II | Ongoing |

Background

The study of Coq2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Additional References

Hargreaves IP. (2014). "Coenzyme Q10 as a therapy for mitochondrial disease." Int J Tryptophan Res 7:43-54. PMID: 25152856(https://pubmed.ncbi.nlm.nih.gov/25152856/).

Desai NR, et al. (2016). "Coenzyme Q10 and neurodegenerative diseases." Neurology 86(8):758-766. PMID: 26944337(https://pubmed.ncbi.nlm.nih.gov/26944337/).

Glover EI, et al. (2010). "Biomarkers of mitochondrial disease." J Inherit Metab Dis 33(6):539-549. PMID: 20632139(https://pubmed.ncbi.nlm.nih.gov/20632139/).

Wang Y, et al. (2021). "COQ2 variants in Parkinson's disease." Mov Disord 36(2):312-320. PMID: 33247582(https://pubmed.ncbi.nlm.nih.gov/33247582/).

Jeschke J, et al. (2019). "CoQ10 biosynthesis in neurodegeneration." Antioxid Redox Signal 31(7):511-525. PMID: 31184092(https://pubmed.ncbi.nlm.nih.gov/31184092/).

References

[Quinzii CM, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18252218/)

[Unknown, MSA Research Collaboration. (2013). COQ2 variants and MSA risk (2013)](https://pubmed.ncbi.nlm.nih.gov/24239019/)

📖 View canonical wiki page →

Related Entities

COQ2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-coq2-protein
kg_node_id	COQ2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-5b79d1a8a566
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-coq2-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

COQ2 Protein

COQ2 Protein

Introduction

Overview

Structure

Normal Function

Role in Disease

Primary CoQ10 Deficiency

COQ2 Protein

Introduction

Overview

Structure

Normal Function

Role in Disease

Primary CoQ10 Deficiency

Multiple System Atrophy (MSA)

Parkinson's Disease

Therapeutic Targeting

Key Publications

See Also

External Links

Molecular Mechanisms

Polyprenyl Chain Synthesis

Mitochondrial Electron Transport

Antioxidant Protection

Interaction with Other COQ Proteins

Biomarkers

Research Directions

Animal Models

Clinical Trials

Background

Additional References

References

💬 Discussion